Radiotherapy of classic and human immunodeficiency virus-related Kaposi's sarcoma: Results in 1482 lesions

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 3, 2008, Pages 297-302

  Caccialanza, M ^a   Marca, S ^a   Piccinno, R ^a   Eulisse, G ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Classic Kaposi's sarcoma; HIV related Kaposi's sarcoma; Radio therapy

Indexed keywords

ALPHA INTERFERON; ANTIRETROVIRUS AGENT;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DERMATITIS; RADIATION DOSE; REMISSION; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; AIDS-RELATED OPPORTUNISTIC INFECTIONS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HIV; HUMANS; MALE; MIDDLE AGED; RADIODERMATITIS; RADIOTHERAPY; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOMA, KAPOSI; SKIN; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 39049099844     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02405.x     Document Type: Article

References (29)

1. Kaposi M. Idiopathic multiple pigmented sarcoma of the skin. Arch Dermatol Syphil 1872; 4: 265-273.
2. Centers for Disease Control and Prevention. Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men - New York City and California. Morb Mortal Wkly Rep 1981; 30: 305-308.
3. Ensoli B, Sgadari C, Barillari G, Sirianni MC, Stürzl M, Monini P. Biology of Kaposi's sarcoma. Eur J Cancer 2001; 37: 1251-1269.
4. Cooper JS. Staging of skin tumors: A mirror of their biologic behaviour. In: Panizzon RG, Cooper JS, eds. Radiation Treatment and Radiation Reactions in Dermatology. Chapter 7. Springer Verlag, Heidelberg, Berlin, New York, 2004: 63-67.
5. Mitsuyasu RT. Clinical variants and staging of Kaposi's sarcoma. Semin Oncol 1987; 14 (Suppl): 13-18.
6. Caccialanza M. Radiotherapy of neoplastic lesions of the eyelid. Ital Gen Rev Dermatol 1989; 26: 221-225.
7. Caccialanza M, Piccinno R, Gnecchi L, Beretta M, Cusini M. Intracavitary contact x-ray therapy of oral HIV-associated Kaposi's sarcoma. Int J STD AIDS 1997; 8: 581-584.
8. Caccialanza M. Radiotherapy for Kaposi's Sarcoma. Ital Gen Rev Dermatol 1989; 26: 242-246.
9. Piccinno R, Caccialanza M, Cusini M. Role of radiotherapy in the treatment of epidemic Kaposi's sarcoma: Experience with sixty-five cases. J Am Acad Dermatol 1995; 32: 1000-1003.
10. Lo TC, Salzman FA, Smedal MI, Wright KA. Radiotherapy for Kaposi's sarcoma. Cancer 1980; 45: 694-687.
11. Tur E, Brenner S. Treatment of Kaposi's sarcoma. Arch Dermatol 1996; 132: 327-331.
12. Fenig E, Brenner B, Rakowsky E, Lapidoth M, Katz A, Sulkes A. Classic Kaposi sarcoma: Experience at Rabin Medical Center in Israel. Am J Clin Oncol 1998; 21: 498-500.
13. Kirova YM, Belembaogo E, Frikha H et al. Radiotherapy in the management of epidemic Kaposi's sarcoma: A retrospective study on 643 cases. Radiother Oncol 1998; 46: 19-22.
14. Piedbois P, Frikha H, Martin L, Levy E, Haddad E, Le Bourgeois JP. Radiotherapy in the management of epidemic Kaposi's sarcoma. Int J Radiat Oncol Biol Phys 1994; 30: 1207-1211.
15. Guillot B, Carles MJ, Foulongne V, Dereure O, Ramuz M. Lack of modification of immunological status after chemotherapy or radiotherapy for classic Kaposi's sarcoma (letter). Br J Dermatol 2002; 146: 337-338.
16. Cooper JS, Sacco J, Newall J. The duration of local control of classic (non-AIDS associated) Kaposi's sarcoma by radiotherapy. J Am Acad Dermatol 1988; 19: 59-66.
17. Lukawska J, Cottrill C, Bower M. The changing role of radiotherapy in AIDS-related malignancies. Clin Oncol (R Coll Radiol) 2003; 15: 2-6.
18. Le Bourgeois JP, Frikha H, Piedbois P, Le Péchoux C, Martin L, Haddad E. Radiotherapy in the management of epidemic Kaposi's sarcoma of the oral cavity, the eyelid and the genitals. Radiother Oncol 1994; 30: 263-266.
19. Watkins EB, Findlay P, Gelmann E, Lane HC, Zabell A. Enhanced mucosal reactions in AIDS patients receiving oropharingeal irradiation. Int J Radiat Oncol Biol Phys 1987; 13: 1403-1408.
20. Hughes-Davis L, Young T, Spittle M. Radiosensitivity in AIDS patients (letter). Lancet 1991; 337: 1616.
21. Tappero JW, Berger TG, Kaplan LD, Volberding PA, Kahn JO. Cryotherapy for cutaneous Kaposi's sarcoma (KS) associated with immunodeficiency syndrome (AIDS): A phase II trial. J Acquir Immune Defic Syndr 1991; 4: 839-846.
22. Marchell N, Alster TS. Successful treatment of cutaneous Kaposi's sarcoma by the 585 nm pulsed dye laser. Dermatol Surg 1997; 23: 973-995.
23. Chun YS, Chang SN, Park WH. A case of classical Kaposi's sarcoma of the penis showing a good response to high-energy pulsed carbon dioxide laser therapy. J Dermatol 1999; 26: 240-243.
24. Tappero JW, Grekin RC, Zanelli GA, Berger TG. Pulsed-dye laser therapy for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. J Am Acad Dermatol 1992; 27: 526-530.
25. Klein E, Schwartz RA, Laor Y, Milgrom H, Burgess GH, Holtermann OA. Treatment of Kaposi's sarcoma with vinblastine. Cancer 1980; 45: 427-431.
26. Epstein JB. Treatment of oral Kaposi sarcoma with intralesional vinblastine. Cancer 1993; 71: 1722-1725.
27. Poigronec S, Lachiver LD, Lamas G, Coutellier A, Caumes E, Soudant J. Intralesional Bleomycin for acquired immunodeficiency Syndrome-associated cutaneous Kaposi's sarcoma. Arch Dermatol 1995; 13: 228.
28. Walmsley S, Northfelt DW, Melosky B, Conant M, Friedman-Kien AE, Wagner B. Treatment of AIDS-related cutaneous Kaposi Sarcoma with topical Alitretinoin (9- cis -retinoic acid) gel. Panretin gel North American Study Group. J Acquir Immune Defic Syndr 1999; 22: 235-246.
29. Bodsworth NJ, Bloch M, Bower M, Donnell D, Yocum R. International Panretin gel KS Study Group. Phase III vehicle-controlled multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma. Am J Clin Dermatol 2001; 2: 77-87.